CVE-2023-39223

Description

Stored cross-site scripting vulnerability exists in CGIs included in A.K.I Software's PMailServer/PMailServer2 products. If this vulnerability is exploited, an arbitrary script may be executed on a logged-in user's web browser.

Category

5.4
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 0.07%
Affected: A.K.I Software pmc.exe
Affected: A.K.I Software pmam.exe
Affected: A.K.I Software pmum.exe (Standard edition)
Affected: A.K.I Software pmum.exe (Pro edition)
Affected: A.K.I Software pmum.exe (Standard + IMAP4 edition)
Affected: A.K.I Software pmum.exe (Pro + IMAP4 edition / Enterprise edition)
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2023-39223?
CVE-2023-39223 has been scored as a medium severity vulnerability.
How to fix CVE-2023-39223?
To fix CVE-2023-39223, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2023-39223 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2023-39223 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-39223?
CVE-2023-39223 affects A.K.I Software pmc.exe, A.K.I Software pmam.exe, A.K.I Software pmum.exe (Standard edition), A.K.I Software pmum.exe (Pro edition), A.K.I Software pmum.exe (Standard + IMAP4 edition), A.K.I Software pmum.exe (Pro + IMAP4 edition / Enterprise edition).
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.